
Neogen Corporation NEOG
$ 9.11
0.22%
Quarterly report 2025-Q4
added 01-08-2026
Neogen Corporation Total Inventories 2011-2026 | NEOG
Annual Total Inventories Neogen Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 191 M | 189 M | 134 M | 122 M | 101 M | 95.1 M | 86 M | 76 M | 73.1 M | 64.4 M | 51.6 M | 51.2 M | 38.3 M | 35 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 191 M | 35 M | 93.4 M |
Quarterly Total Inventories Neogen Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 163 M | 193 M | 191 M | 205 M | 198 M | 199 M | 189 M | 182 M | 161 M | 141 M | 134 M | 144 M | 136 M | 129 M | 122 M | 113 M | 107 M | 102 M | 101 M | 101 M | 92.5 M | 97.6 M | 95.1 M | 89.2 M | 86.4 M | 87.7 M | 86 M | 86 M | 79.5 M | 78.8 M | 76 M | 76 M | 73.7 M | 73.4 M | 73.1 M | 73.1 M | 71.7 M | 69.8 M | 64.4 M | 64.4 M | 61.5 M | 56.1 M | 51.6 M | 51.6 M | 53.5 M | 55.1 M | 51.2 M | 51.2 M | 47.3 M | 43.8 M | 38.3 M | 38.3 M | 38.4 M | 35 M | 35 M | 35 M | 36.4 M | 34.2 M | 32 M | 32 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 205 M | 32 M | 91.4 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M | ||
|
Bioventus
BVS
|
82.2 M | $ 8.87 | 2.9 % | $ 591 M | ||
|
Charles River Laboratories International
CRL
|
299 M | $ 151.97 | -2.34 % | $ 7.53 B | ||
|
Castle Biosciences
CSTL
|
8.14 M | $ 25.83 | 1.06 % | $ 717 M | ||
|
CareDx, Inc
CDNA
|
26.7 M | $ 17.32 | 1.82 % | $ 923 M | ||
|
DexCom
DXCM
|
629 M | $ 66.34 | 3.27 % | $ 25.9 B | ||
|
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
166 M | $ 103.85 | 0.27 % | $ 19.6 B | ||
|
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | ||
|
Guardant Health
GH
|
85.9 M | $ 87.18 | 1.98 % | $ 10.9 B | ||
|
Danaher Corporation
DHR
|
2.49 B | $ 191.39 | 2.17 % | $ 136 B | ||
|
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
2.3 M | $ 97.61 | -0.73 % | $ 8.05 B | ||
|
Illumina
ILMN
|
547 M | $ 119.28 | 0.29 % | $ 19 B | ||
|
Quest Diagnostics Incorporated
DGX
|
189 M | $ 198.94 | -0.38 % | $ 22.1 B | ||
|
QIAGEN N.V.
QGEN
|
279 M | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
830 M | $ 111.83 | 0.28 % | $ 34 B | ||
|
BioNano Genomics
BNGO
|
13.3 M | $ 1.11 | - | $ 1.41 M | ||
|
DarioHealth Corp.
DRIO
|
5.06 M | $ 8.42 | -6.44 % | $ 239 M | ||
|
Lantheus Holdings
LNTH
|
64.7 M | $ 78.5 | -1.25 % | $ 5.3 B | ||
|
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
1.66 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
387 M | $ 1 198.71 | 2.13 % | $ 24.7 B | ||
|
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | ||
|
NeoGenomics
NEO
|
28.6 M | $ 8.24 | 4.57 % | $ 1.06 B | ||
|
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M | ||
|
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
35.4 M | $ 197.68 | 5.23 % | $ 19.5 B | ||
|
OPKO Health
OPK
|
56.8 M | $ 1.19 | - | $ 826 M | ||
|
Pacific Biosciences of California
PACB
|
49.3 M | $ 1.36 | 2.26 % | $ 408 M |